Hrt Financial LP Calyxt, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.13 - $0.2 $5,245 - $8,069	40,348 New	40,348 $5,000
Q4 2021 Feb 14, 2022	SELL	$2.06 - $4.05 $45,490 - $89,436	-22,083 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.18 - $5.08 $21,347 - $34,102	-6,713 Reduced 23.31%	22,083 $74,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $6.31 $110,288 - $181,702	28,796 New	28,796 $115,000
Q1 2020 May 15, 2020	SELL	$2.48 - $7.85 $28,257 - $89,442	-11,394 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.6 - $7.27 $41,018 - $82,834	11,394 New	11,394 $79,000
Q1 2019 May 14, 2019	SELL	$10.38 - $18.97 $108,585 - $198,445	-10,461 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$9.33 - $14.99 $97,601 - $156,810	10,461 New	10,461 $108,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.